Accepted Manuscript
Combined intake of astaxanthin, β -carotene, and resveratrol elevates protein synthesis during muscle hypertrophy in mice Aki Kawamura M.Sc. , Wataru Aoi Ph.D. , Ryo Abe M.Sc. , Yukiko Kobayashi Ph.D. , Sayori Wada M.D., Ph.D. , Masashi Kuwahata Ph.D. , Akane Higashi M.D., Ph.D. PII: DOI: Article Number: Reference:
S0899-9007(19)30120-0 https://doi.org/10.1016/j.nut.2019.110561 110561 NUT 110561
To appear in:
Nutrition
Received date: Revised date: Accepted date:
15 February 2019 23 April 2019 12 May 2019
Please cite this article as: Aki Kawamura M.Sc. , Wataru Aoi Ph.D. , Ryo Abe M.Sc. , Yukiko Kobayashi Ph.D. , Sayori Wada M.D., Ph.D. , Masashi Kuwahata Ph.D. , Akane Higashi M.D., Ph.D. , Combined intake of astaxanthin, β -carotene, and resveratrol elevates protein synthesis during muscle hypertrophy in mice, Nutrition (2019), doi: https://doi.org/10.1016/j.nut.2019.110561
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
Highlights ・Combined intake of astaxanthin, β-carotene, and resveratrol accelerated muscle hypertrophy. ・Along with the muscle hypertrophy, protein synthesis signaling was activated.
AC
CE
PT
ED
M
AN US
CR IP T
・These effects might be mediated by oxidative stress reduction.
1
ACCEPTED MANUSCRIPT
Combined intake of astaxanthin, β-carotene, and resveratrol elevates protein synthesis during muscle hypertrophy in mice Aki Kawamura M.Sc.a,b, Wataru Aoi Ph.D.a,*, Ryo Abe M.Sc.a,c, Yukiko Kobayashi Ph.D.a,
a
CR IP T
Sayori Wada M.D., Ph.D.a, Masashi Kuwahata Ph.D.a , Akane Higashi M.D., Ph.D.a
Division of Applied Life Sciences, Graduate School of Life and Environmental Sciences,
AN US
Kyoto Prefectural University, Kyoto, Japan
Sports Science Research Promotion Center, Nippon Sport Science University, Tokyo, Japan
c
Wakayama Medical University Hospital, Wakayama, Japan
M
b
[email protected]
ED
*Corresponding author: Wataru Aoi, Tel.: +81757035417, Fax: +81757035417, E-mail address:
PT
Running head: Combined antioxidants accelerate muscle hypertrophy
CE
Word count: 4985
AC
Number of figures and tables: 5 figures Authors contribution: A.K. and W.A. designed and coordinated the study. A.K., W.A., and R.A. contributed to designing and performed experiments. A.K., W.A., Y.K., S.W., M.K., and A.H. analyzed and evaluated data. A.K. and W.A. wrote the manuscript with input from other authors. All authors critically reviewed and approved the final version of manuscript.
2
ACCEPTED MANUSCRIPT
Abstract Objective: The antioxidant factors, astaxanthin, β-carotene, and resveratrol, have a potential effect on protein synthesis in skeletal muscle and a combined intake may have a greater
CR IP T
cumulative effect than individual intake. We investigated the combined effects on skeletal muscle mass and protein metabolic signaling during hypertrophic process from atrophy in mice.
AN US
Research Methods and Procedures: Male ICR mice were divided into 5 diet groups consisting of 7 animals: normal, astaxanthin, β-carotene, resveratrol, and all 3 antioxidants. Equal concentrations (0.06% (w/w)) of the respective antioxidants were included in the diet of each
M
group. In the mixed group, 3 antioxidants were added in equal proportion. One leg in all mice
ED
was casted for 3 weeks to induce muscle atrophy. After removal of the cast, the mice were fed each diet for 2 weeks. The muscle tissues were collected, weighed, and examined for protein
PT
metabolism signaling and oxidative damage.
CE
Results: The weight of soleus muscle was increased in the astaxanthin, β-carotene, and
AC
resveratrol groups to a greater extent in comparison to in the normal group; this was accelerated by intake of the mix antioxidants (p=0.007). Phosphorylation levels of mTOR and p70S6K in the muscle were higher in the mixed antioxidant group than in the normal group (p=0.025, p=0.020). The carbonylated protein concentration was lower in the mixed antioxidant group than in the normal group (p=0.021).
3
ACCEPTED MANUSCRIPT
Conclusions: These results suggest that a combination of astaxanthin, β-carotene, and resveratrol, even in small amounts, promoted protein synthesis during the muscle hypertrophic process following atrophy.
CR IP T
Keywords: antioxidant, muscle hypertrophy, protein synthesis, oxidative stress, combined
AN US
intake
Introduction
To increase muscle mass, it is important to increase protein content by modulating protein
M
metabolism. Namely, accelerating protein synthesis and preventing protein catabolism promote
ED
muscle hypertrophy. Resistance training is the most established way to enhance protein synthesis. It is well known that appropriate nutrition accelerates the improvement of muscle
PT
strength and mass by resistance training. Specifically, sufficient intake of dietary protein
CE
improves exercise-induced protein synthesis more than poor intake below the recommended
AC
dietary intake [1]. In addition to protein, several amino acids and peptides can also stimulate muscle protein synthesis [2-5]. A combined intake of carbohydrate and protein is more effective in increasing muscle protein by stimulating insulin secretion [6]. However, it is unclear whether micronutrients with antioxidant capacity can stimulate muscle hypertrophy during resistance training.
4
ACCEPTED MANUSCRIPT
The effect of oxidative stress on protein metabolism in skeletal muscle has been investigated. Chronic oxidative stress, which is associated with disuse atrophy, induces proteolysis of the muscle [7]. Dietary antioxidant intervention has been shown to prevent
CR IP T
protein catabolism during atrophy [8-10]. In contrast, the evidence that oxidative stress is involved in the process of protein synthesis has been limited. However, some antioxidants can
AN US
stimulate protein synthesis signaling. Oral administration of β-carotene, a carotenoid, increased the phosphorylation level of p70S6 kinase (p70S6K) and promoted protein synthesis [11]. Resveratrol, a polyphenol, has been shown to stimulate insulin growth factor-1-mediated
M
signaling, in particular Akt and ERK 1/2 protein, and promote hypertrophy in cultured muscle
ED
cells [12]. Another study showed that resveratrol activated phosphorylation level of Akt, mammalian target of rapamycin (mTOR), p70S6K, 4E-BP1, and increased muscle mass [13].
PT
Astaxanthin, a xanthophyll carotenoid, also modulated muscle protein metabolism and
CE
accelerated strength in animals and humans [14-16]. Thus, we hypothesized that these 3
AC
antioxidants can promote muscle mass by stimulating protein anabolism during hypertrophy. Various antioxidants are localized at different cellular positions in the living body. Their
antioxidant functions are balanced/maintained by electron transfer. In many cases, the antioxidant capacity is higher with the combined intake of several antioxidants compared to that with individual intake [17, 18]. Thus, the combined intake of several antioxidants, even in
5
ACCEPTED MANUSCRIPT
small amounts, may exert more antioxidant functions as reduced oxidative maker, i.e. carbonylated proteins than individual intake in greater amounts. Therefore, we hypothesized that combined intake of astaxanthin, β-carotene, and resveratrol may efficiently enhance
CR IP T
muscle protein synthesis. Here, we investigated the effect of combined antioxidant intake on protein anabolic signals using a mouse model that show muscle hypertrophy after
AN US
immobilization-induced atrophy.
Material and Methods
M
Animals and experimental design
ED
Care of all animals in the study complied with the guidelines of the Japanese Council on Animal Care and was approved by the Committee for Animal Research of the Kyoto Prefectural
PT
University (KPU028526). The experimental design is shown in Fig. 1. A total of 44 ICR male
CE
mice (7 weeks old; Shimizu Laboratory Supplies Co., Ltd., Kyoto, Japan) were acclimatized for
AC
1 week in an air-conditioned (22 ± 2°C) room with a 12:12-h light-dark cycle (lights on from 0800 to 2000). Then, characteristic of 9 mice were measured immediately after casting, and the other mice were divided into 5 groups with 7 mice each: normal, astaxanthin, β-carotene, resveratrol, and mix antioxidant (mixture of three antioxidants) diet groups. According to the previous study [19], the knee and ankle joints of one hindlimb were fixed with cast, and muscle
6
ACCEPTED MANUSCRIPT
atrophy was induced. After 3 weeks, the cast was removed, and soleus and gastrocnemius muscles from both legs of the 9 mice were weighed. The remaining 5 groups of mice maintained their diets for 2 weeks after cast removal. Each antioxidant (astaxanthin, Fuji
CR IP T
Chemical Industries Co., Ltd., Toyama, Japan; β-carotene, Sigma-Aldrich, St. Louis, MO, USA; resveratrol, BGG Japan Co. Ltd., Tokyo, Japan) was added to the baseline diet (MF, Shimizu
AN US
Laboratory Supplies Co., Ltd., Kyoto, Japan) containing protein, 23.1 g%; fat, 5.1 g%; carbohydrate, 55.3 g%; retinol, 1283 IU%; α-tocopherol, 9.1 mg%; and ascorbic acid, 4 mg%. Referring to previous studies that showed improvement of skeletal muscle functions in rodents
M
[11, 20, 21], the effective concentration of 3 antioxidants was estimated to be 0.02% and the
ED
mix antioxidant diet was prepared with equal proportion of 0.02% each (total concentration 0.06%). Then, equal concentrations (0.06%) of the respective antioxidants were included in the
PT
diet of each group. Plasma concentration of each antioxidant is assumed to be elevated after
CE
supplementation, from information of previous studies [22-24]. There was no difference in food
AC
intake between groups. After 2 weeks, the body weight (B.W.) of all mice was measured, euthanized under anesthesia, and then blood and soleus and gastrocnemius muscles from both legs were collected. After measuring the weight of the muscle tissues, the tissues were stored at -80 °C until biochemical experiments.
7
ACCEPTED MANUSCRIPT
Western blotting The soleus muscles were homogenized using stainless beads and a crushing machine (Shakeman 3, BMS, Tokyo, Japan) in lysis buffer (CellLytic MT Cell Lysis Reagent;
CR IP T
Sigma-Aldrich) added protease inhibitor cocktail (Sigma-Aldrich) and phosphatase inhibitor cocktail (Nacalai Tesque, Kyoto, Japan). Protein was extracted from the muscle tissue by
AN US
centrifugation at 16,000 rpm for 15 min at 4°C. Protein concentration of the supernatant was measured using the BCA method (BCA Protein Assay Kit; Thermo Fisher Scientific, Waltham, MA, USA). Equal amounts of protein were separated by SDS-polyacrylamide gel
M
electrophoresis and then transferred into nitrocellulose membranes (iBlot® Gel Transfer Stacks
ED
Nitrocellulose; Thermo Fisher Scientific). Subsequently, the blots were incubated overnight at 4°C with primary antibodies against phospho-mTOR (Ser2481), total mTOR, phospho-p70S6K
PT
(Thr389), total p70S6K, phospho-Akt (Ser473), total Akt, phospho-FoxO1 (Ser256), total
CE
FoxO1 (Cell Signaling Technology, Beverly, MA, USA), and glyceraldehyde-3-phosphate
AC
dehydrogenase (GAPDH) (Abcam Co., Ltd., Cambridge, MA, USA). Then, membranes were incubated with a horseradish peroxidase-conjugated secondary antibody and enhanced chemiluminescence substrate (Chemi-Lumi One Super; Nacalai Tesque). The detected bands were visualized by image analysis (LuminoGraphⅢ, ATTO Corporation, Tokyo, Japan) and signal intensities were quantified using an image analyzer (Image Saver 6, ATTO Corporation).
8
ACCEPTED MANUSCRIPT
Carbonylated protein Carbonylated protein concentration in protein lysate obtained from soleus muscle tissues
CR IP T
was measured using the enzyme-linked immunosorbent assay kit (BioCell Corporation Ltd.,
AN US
Auckland, New Zealand), according to the manufacturer’s instruction.
Statistical analysis
All data are expressed as mean ± standard errors. IBM SPSS Statistics for Windows
M
version 18 (IBM Japan Inc., Tokyo, Japan) was used for the statistical analysis. Differences
ED
between multiple groups were evaluated using a 1-way or 2-way analysis of variance. When significant interactions were detected, multiple comparison tests were conducted using the
PT
Dunnett’s or the Tukey tests. Differences within a group were evaluated using paired t-tests. A
AC
CE
p-value of < 0.05 was considered to be statistically significant.
Results
1. Skeletal muscle mass Immediately after cast removal, weights of both the gastrocnemius and soleus muscles were markedly lower in the casted leg than in the control leg (p < 0.001) (Fig. 2A, B). Two
9
ACCEPTED MANUSCRIPT
weeks after the removal, the soleus weight was significantly lower in the casted leg (0.20 ± 0.01 mg/g B.W.) than in the control leg (0.27 ± 0.01 mg/g B.W.) in the normal diet group (p = 0.010) (Fig. 3A). In contrast, it was significantly higher in the casted leg (0.24 ± 0.01 mg/g B.W.) than
CR IP T
in the control leg (0.20 ± 0.01 mg/g B.W.) in the mix antioxidant diet group (p = 0.027) and not significantly different between both legs in other antioxidant groups. In addition, the ratio of
AN US
relative weight of the casted leg to the control leg was significantly higher in the mix antioxidant diet group (17.1 ± 5.7%, p = 0.007) and astaxanthin diet group (9.8 ± 10.0%, p = 0.026) than in the normal diet group (-25.6 ± 6.6%) (Fig. 3B). In contrast to no significant
M
difference in the weight of gastrocnemius muscle between groups, gastrocnemius muscle weight
ED
from the casted leg was significantly smaller than that from the control leg in all groups (Fig.
PT
3C, D). Thus, further biochemical analyses were performed for the soleus muscle.
CE
2. Protein metabolic signaling in the skeletal muscle
AC
Total protein concentration (μg/mg wet weight) in the casted soleus muscle was not significantly different between groups (normal, 60.5 ± 2.4; astaxanthin, 55.3 ± 2.1; β-carotene, 59.5 ± 3.3; resveratrol, 63.0 ± 3.3; mix antioxidant, 62.0 ± 3.0). In addition, there was no significant difference when it was compared with the protein concentration from the control muscle (normal, 54.9 ± 2.4; astaxanthin, 62.2 ± 3.1; β-carotene, 66.3 ± 4.1; resveratrol, 61.7 ±
10
ACCEPTED MANUSCRIPT
5.4; mix antioxidant, 66.9 ± 3.8). Thus, these results suggest that muscle hypertrophy was caused by the increase in protein contents, but not by changes in other components, such as water. We then measured protein metabolism-related signaling factors in the soleus muscle from
CR IP T
the casted leg.
Phosphorylation of mTOR, a key anabolic signal factor, was significantly higher in the mix
AN US
antioxidant diet group (244 ± 54%) than in the normal diet group (100 ± 23%) (p = 0.025) (Fig. 4A). The down-stream factor of mTOR, phospho-p70S6K was also significantly higher in the mix antioxidant diet group (149 ± 15%) than in the normal group (100 ± 11%) (p = 0.020) (Fig.
M
4B). No significant difference in phospho-Akt level were found between groups (Fig. 4C). In
ED
contrast, phosphorylation of FoxO1, a key catabolic signal factor, was not significantly different
PT
in antioxidant treatment groups in comparison to the normal group (Fig. 4D).
CE
3. Carbonylated protein in the skeletal muscle
AC
Carbonylated protein, an oxidative damage marker, was measured in the soleus muscle from the casted leg. The concentration of carbonylated protein was significantly lower in the mix antioxidant group (3.59 ± 0.09 nmol/mg protein) but not in other antioxidant groups compared with that in the normal group (3.94 ± 0.05 nmol/mg protein, p = 0.021) (Fig. 5).
11
ACCEPTED MANUSCRIPT
Discussion Many previous studies have examined the effect of dietary antioxidants intervention on protein catabolism and muscle atrophy [8-10]. In contrast, their effects on protein synthesis and
CR IP T
hypertrophy have not yet been clarified. We examined whether specific antioxidants can have protein anabolic effect during the recovery from atrophy. Although the weight of the soleus
AN US
muscle of the casted leg recovered for over 2 weeks of hypertrophic period after cast removal, it was still lower than that of the control leg under the baseline diet condition. However, no differences between control and casted legs were observed in the astaxanthin, β-carotene, and
M
resveratrol diet groups. Furthermore, in the group that received three antioxidants, the weight of
ED
muscle of the casted leg was rather higher than that of the control leg. Repetitive mechanical overload to skeletal muscle induces hypertrophy. As an adaptation to resistance exercise training,
PT
the common mechanism is associated with muscle hypertrophy during recovery after
CE
immobilization. Thus, the muscle weight can surpass that of the normal group, along with the
AC
timing of recovery and hypertrophic activity. The results suggest that the supplementation of mixed antioxidants stimulates protein synthesis, resulting in muscle hypertrophy beyond the basal level. These results firstly indicated that astaxanthin, β-carotene, and resveratrol promoted muscle hypertrophy during recovery after atrophy, and this effect was accelerated by combined intake of these antioxidants.
12
ACCEPTED MANUSCRIPT
Several signal transduction pathways are involved in protein synthesis and degradation. Phosphorylation levels of Akt, mTOR, and p70S6K, key molecules in the protein synthesis pathway, are increased during the muscle hypertrophic period in resistance training [25]. Muscle
CR IP T
contraction accompanying exercise promotes growth factors and then activates Akt, resulting in activation of the downstream mTOR/p70S6K signal [2, 26-28]. In contrast, FoxO1, the key
AN US
molecule in proteolysis is activated in bedridden, inactive, and space environment [29]. It activates the downstream MuRF-1, Atrogin-1, and ubiquitin-proteasome system, promotes protein degradation, and induces atrophy [30, 31]. We showed that combined intake of
M
astaxanthin, β-carotene, and resveratrol increases the phosphorylation level of mTOR and
ED
p70S6K but not FoxO1, suggesting that these compounds promoted protein synthesis. Because the phosphorylation level of Akt was not changed by antioxidant diet, other upstream pathways
PT
can be involved in the activation of mTOR/p70S6K. Phosphorylation of mTOR and p70S6K is
CE
not always mediated by the activation of Akt. Hara et al. [2] revealed that amino acids
AC
phosphorylate S6K and 4EBP1 without activating the insulin signaling pathway in cultured cells, which are mediated by Rag, Vps34, and MAP4K3, putative intracellular amino acid sensors. Along with the results in muscle weight and anabolic signaling, carbonylated protein, a
typical oxidative marker, was lower in the mix antioxidant diet group than the normal diet group. This marker has been used in many studies to examine oxidative stress level in skeletal muscle
13
ACCEPTED MANUSCRIPT
in various experimental conditions [32-34]. Furthermore, protein carbonylation is an irreversible posttranslational modification of proteins and the modified protein can be inactivated or catabolized. Thus, elevation of carbonylated protein shows protein dysfunction as well as higher
CR IP T
oxidative stress. It is well known that chronic oxidative stress stimulates proteolysis and induces muscle atrophy. In addition, several studies suggest that protein synthesis signal can be
AN US
negatively regulated by excessive oxidative stress [35-37]. A high level of oxidative stress inhibits anabolic signaling by reducing phosphorylation of mTOR and 4EBP1 in cultured muscle cells [38]. In this case, antioxidants might have a positive effect that activates the signal
M
transduction by scavenging excess ROS. Here, the mix antioxidant diet had the largest effect on
ED
muscle hypertrophy even with an equal amount of total antioxidant in the diet, which supports the concept that it activates protein synthesis signaling via increased antioxidant capacity.
PT
Antioxidants have different characteristics in the living body. They accumulate in various
CE
cellular components and scavenge radicals with the individual characteristics. Additionally,
AC
some antioxidants could be changed to prooxidants in particular conditions such as high-dose intake of a single compound. Thus, radicals are efficiently eliminated by contracted redox chain reaction when several compounds are ingested in combination. Indeed, previous studies have shown, in various experimental models, that oxidative stress in humans and mice is lower with combined intake of antioxidants than with individual intake [39, 40]. In the muscle tissues after
14
ACCEPTED MANUSCRIPT
exercise, combined intake of antioxidants also reduced oxidative stress compared to individual intake [41]. Lipid-soluble astaxanthin and β-carotene are easily accumulated in plasma and mitochondrial membranes. Astaxanthin scavenges radicals both inside and outside the
CR IP T
membrane sites since it penetrates across the membrane [42]. β-carotene rather works in the membrane since it exists in a bundled form in the membrane [42]. In contrast, resveratrol works
AN US
at the cytosol and intracellular components [43]. These individual characteristics might lead to higher antioxidant effect even with intake of a small dose.
The production of ROS is larger in slow-twitch fiber, which is enriched in the soleus
M
muscle, than in fast-twitch fiber. It contains high density of mitochondria, a major source of
ED
ROS with energy production [44]. Several studies reported that dietary antioxidant was effective in reduction of ROS and ameliorated atrophy in the soleus muscle more than the gastrocnemius
PT
muscle, which contains more fast-twitch fibers [7-11]. In this study, the hypertrophic effect of
CE
antioxidant intake was observed in the soleus muscle, which might easily generate the
AC
antioxidant effects.
Phytochemical compounds that have antioxidant capacity, have individual effects apart
from antioxidant properties. Astaxanthin, β-carotene, and resveratrol which have positive effects on protein synthesis. In contrast, some reports have shown that several antioxidants including vitamin C and E did not change [45, 46] or rather negatively [47-50] regulate the metabolism in
15
ACCEPTED MANUSCRIPT
exercise conditions. Although the reason for the difference in compounds is unclear, we cannot deny that their protein synthesis effects were not caused by antioxidant effects. Namely, both hypertrophic and antioxidant effects might independently occur in parallel. Further studies
CR IP T
should be required to clarify whether the protein synthesis enhanced by the 3 compounds is mediated by reduction of oxidative stress. In addition, this study was performed in a limited
AN US
condition, e.g., dose and type of compounds. An investigation on the effects of other antioxidants and their combination is also needed. Considerably, our findings support that combined intake of antioxidants is beneficial for muscle metabolism in the hypertrophic period.
M
Conclusion
ED
This study examined the effect of antioxidants intake on protein synthesis and muscle mass during the hypertrophic period after immobilization-induced atrophy. Astaxanthin, β-carotene,
PT
and resveratrol increased protein synthesis signaling and muscle mass, and the combined intake
CE
of antioxidants showed the greatest effect. These effects might be mediated by oxidative stress
AC
reduction.
Acknowledgements This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (No.17H02176).
16
ACCEPTED MANUSCRIPT
Conflict of Interest The authors declare that there is no conflict of interest associated with this manuscript.
CR IP T
References
[1] Churchward-Venne TA, Burd NA, Phillips SM. Nutritional regulation of muscle protein
AN US
synthesis with resistance exercise: strategies to enhance anabolism. Nutr Metab 2012; 9:40. [2] Hara K, Yonezawa K, Weng QP, Kozlowski MT, Belham C, Avruch J. Amino acid sufficiency and mTOR regulate p70S6 kinase and eIF-4E BP1 through a common effector
M
mechanism. J Biol Chem 1998; 273:14484-14494.
ED
[3] Patti ME, Brambilla E, Luzi L, Landaker EJ, Kahn CR. Bidirectional modulation of insulin action by amino acids. J Clin Invest 1998; 101:1519-1529.
PT
[4] Wang X, Campbell LE, Miller CM, Proud CG. Amino acid availability regulates p70S6
CE
kinase and multiple translation factors. Biochem J 1998; 334 (1):261-267.
AC
[5] Iiboshi Y, Papst PJ, Kawasome H, Hosoi H, Abraham RT, Houghton PJ, et al. Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation. J Biol Chem 1999; 274:1092-1099.
[6] Ivy JL, Goforth HW Jr., Damon BM, McCauley TR, Parsons EC, Price TB. Early postexercise muscle glycogen recovery is enhanced with a carbohydrate-protein
17
ACCEPTED MANUSCRIPT
supplement. J Appl Physiol (1985) 2002; 93:1337-1344. [7] Kondo H, Miura M, Itokawa Y. Oxidative stress in skeletal muscle atrophied by immobilization. Acta Physiol Scand 1991; 142:527-528.
CR IP T
[8] Yoshihara T, Yamamoto Y, Shibaguchi T, Miyaji N, Kakigi R, Naito H, et al. Dietary astaxanthin supplementation attenuates disuse-induced muscle atrophy and myonuclear
AN US
apoptosis in the rat soleus muscle. J Physiol Sci 2017; 67:181-190.
[9] Ogawa M, Kariya Y, Kitakaze T, Yamaji R, Harada N, Sakamoto T, et al. The preventive effect of β-carotene on denervation-induced soleus muscle atrophy in mice. Br J Nutr 2013;
M
109:1349-1358.
ED
[10] Appell HJ, Duarte JA, Soares JM. Supplementation of vitamin E may attenuate skeletal muscle immobilization atrophy. Int J Sports Med 1997; 18:157-160.
PT
[11] Kitakaze T, Harada N, Imagita H, Yamaji R. β-Carotene increases muscle mass and
CE
hypertrophy in the soleus muscle in mice. J Nutr Sci Vitaminol 2015, 61:481-487.
AC
[12] Montesano A, Luzi L, Senesi P, Mazzocchi N, Terruzzi I. Resveratrol promotes myogenesis and hypertrophy in murine myoblasts. J Transl Med 2013; 11:310.
[13] Wang DT, Yin Y, Yang YJ, Lv PJ, Shi Y, Lu L, et al. Resveratrol prevents TNF-alpha-induced muscle atrophy via regulation of Akt/mTOR/FoxO1 signaling in C2C12 myotubes. Int Immunopharmacol 2014; 19:206-213.
18
ACCEPTED MANUSCRIPT
[14] Shibaguchi T, Yamaguchi Y, Miyaji N, Yoshihara T, Naito H, Goto K, et al. Astaxanthin intake attenuates muscle atrophy caused by immobilization in rats. Physiol Rep 2016; 4:e12885.
supplementation
attenuates
immobilization-induced
CR IP T
[15] Maezawa T, Tanaka M, Kanazashi M, Maeshige N, Kondo H, Ishihara A, et al. Astaxanthin skeletal
muscle
fibrosis
via
AN US
suppression of oxidative stress. J Physiol Sci 2017; 67: 603-611.
[16] Curt L. Malmstena AL. Dietary Supplementation with Astaxanthin-rich algal meal improves strength endurance –A double blind placebo controlled study on male students–.
M
Carotenoid Sci 2008; 13:20-22.
ED
[17] Rizzo MR, Abbatecola AM, Barbieri M, Vietri MT, Cioffi M, Grella R, et al. Evidence for anti-inflammatory effects of combined administration of vitamin E and C in older persons
PT
with impaired fasting glucose: impact on insulin action. J Am Coll Nutr 2008; 27:505-511.
CE
[18] Chao WH, Askew EW, Roberts DE, Wood SM, Perkins JB. Oxidative stress in humans
AC
during work at moderate altitude. J Nutr 1999; 129:2009-2012. [19] Aoi W, Naito Y, Mizushima K, Takanami Y, Kawai Y, Ichikawa H, et al. The microRNA miR-696 regulates PGC-1α in mouse skeletal muscle in response to physical activity. Am J Physiol Endocrinol Metab 2010; 298:799-806. [20] Aoi W, Naito Y, Sakuma K, Kuchide M, Tokuda H, Maoka T, et al. Astaxanthin limits
19
ACCEPTED MANUSCRIPT
exercise-induced skeletal and cardiac muscle damage in mice. Antioxid Redox Signal 2003; 5:139-144. [21] Song L, Chen L, Zhang X, Li J, Le W. Resveratrol ameliorates motor neuron degeneration
CR IP T
and improves survival in SOD1G93A mouse model of amyotrophic lateral sclerosis. Biomed Res Int 2014; 483501.
AN US
[22] Aoi W, Maoka T, Abe R, Fujishita M, Tominaga K, Comparison of the effect of non-esterified and esterified astaxanthins on endurance performance in mice. J Clin Biochem Nutr 2018; 62: 161-166.
M
[23] Umegaki K, Aoshima M, Hirota S, Uramoto H, Esashi T, Simultaneous dietary
ED
supplementation of sodium cholate and beta-carotene markedly enhances accumulation of beta-carotene in mice. J Nutr 1995; 125: 3081-3086.
PT
[24] Oomen CA, Farkas E, Roman V, van der Beek,EM, Luiten PG, Meerlo P, Resveratrol
CE
preserves cerebrovascular density and cognitive function in aging mice. Front Aging
AC
Neurosci 2009; 1:1-9. [25] Lim CH, Luu TS, Phoung LQ, Jeong TS, Kim CK. Satellite cell activation and mTOR signaling pathway response to resistance and combined exercise in elite weight lifters. Eur J Appl Physiol 2017; 117:2355-2363. [26] Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H, et al. mTOR
20
ACCEPTED MANUSCRIPT
interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110:163-175. [27] Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, et al. Mammalian TOR
CR IP T
complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6:1122-1128.
AN US
[28] Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14:1296-1302.
M
[29] Brocca L, oniolo L, Reggiani C, Bottinelli1 R, Sandri M, Pellegrino MA, et al.
ED
FoxO-dependent atrogenes vary among catabolic conditions and play a key role in muscle atrophy induced by hindlimb suspension. J Physiol 2017; 595:1143-1158.
PT
[30] Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, et al. FoxO transcription
CE
factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle
AC
atrophy. Cell 2004; 117:399-412. [31] Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704-1708.
[32] Park CH, Ju TJ, Kim YW, Dan JM, Kim JY, Kim YD, et al. Hemin, heme oxygenase-1 inducer, attenuates immobilization-induced skeletal muscle atrophy in mice. Life Sci 2013;
21
ACCEPTED MANUSCRIPT
92:740-746. [33] Ota N, Soga S, Haramizu S, Yokoi Y, Hase T, Murase T. Tea catechins prevent contractile dysfunction in unloaded murine soleus muscle: a pilot study. Nutrition 2011; 27: 955-959.
CR IP T
[34] Morillas-Ruiz J, Zafrilla P, Almar M, Cuevas MJ, Lo´pez FJ, Abella´n P, et al. The effects of an antioxidant-supplemented beverage on exercise-induced oxidative stress: results from
AN US
a placebo-controlled double-blind study in cyclists. Eur J Appl Physiol 2005; 95:543-549. [35] Hawley JA, Burke LM, Phillips SM, Spriet LL. Nutritional modulation of training-induced skeletal muscle adaptations. J Appl Physiol 2011; 110:834-845.
M
[36] Li YP, Chen Y, Li AS, Reid MB. Hydrogen peroxide stimulates ubiquitin-conjugating
ED
activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 2003; 285:806-812.
PT
[37] Tan PL, Shavlakadze T, Grounds MD, Arthur PG. Differential thiol oxidation of the
CE
signaling proteins Akt, PTEN or PP2A determines whether Akt phosphorylation is
AC
enhanced or inhibited by oxidative stress in C2C12 myotubes derived from skeletal muscle. Int J Biochem Cell Biol 2015; 62:72-79.
[38] Zhang L, Kimball SR, Jefferson LS, Shenberger JS. Hydrogen peroxide impairs insulin-stimulated assembly of mTORC1. Free Radic Biol Med 2009; 46:1500-1509. [39] Niki E, Saito T, Kawakami A, Kamiya Y. Inhibition of oxidation of methyl linoleate in
22
ACCEPTED MANUSCRIPT
solution by vitamin E and vitamin C. J Biol Chem 1984; 259:4177-4182. [40] Nakano M, Onodera A, Saito E, Tanabe M, Yajima K, Takahashi J, et al. VC: Effect of
diabetic ODS rats. J Nutr Sci Vitaminol 2008; 54:329-334.
CR IP T
astaxanthin in combination with α-tocopherol or ascorbic acid against oxidative damage in
[41] Wawrzyniak A, Górnicka M, Hamułka J, Gajewska M, Drywień M, Pierzynowska J, et al.
AN US
α-Tocopherol, ascorbic acid, and β-carotene protect against oxidative stress but reveal no direct influence on p53 expression in rats subjected to stress. Nutr Res 2013; 33(10): 868-875.
M
[42] Goto S, Kogure K, Abe K, Kimata Y, Kitahama K, Yamashita E, et al. Efficient radical
ED
trapping at the surface and inside the phospholipid membrane is responsible for highly potent antiperoxidative activity of the carotenoid astaxanthin. Biochim Biophys Acta 2001;
PT
1512:251-258.
CE
[43] Cucciolla V, Borriello A, Oliva A, Galletti P, Zappia V, Ragione FD, et al. Resveratrol:
AC
from basic science to the clinic. Cell Cycle 2007; 6:2495-2510. [44] Indo HP, Davidson M, Yen HC, Suenaga S, Tomita K, Nishii T, et al. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007; 7:106-118. [45] Theodorou A, Nikolaidis M, Paschalis V, Koutsias S, Panayiotou G, Fatouros I, et al. No
23
ACCEPTED MANUSCRIPT
effect of antioxidant supplementation on muscle performance and blood redox status adaptations to eccentric training. Am J Clin Nutr 2011; 93:1373-1383. [46] Higashida K, Kim SH, Higuchi M, Holloszy J, Han D. Normal adaptations to exercise
CR IP T
despite protection against oxidative stress. Am J Physiol Endocrinol Metab 2011; 301:779-784.
AN US
[47] Makanae Y, Kawada S, Sasaki K, Nakazato K, Ishii N. Vitamin C administration attenuates overload‐induced skeletal muscle hypertrophy in rats. Acta Physiologica 2013; 208:57-65. [48] Paulsen G, Hamarsland H, Cumming KT, Johansen RE, Hulmi JJ, Borsheim E, et al.
M
Vitamin C and E supplementation alters protein signalling after a strength training session,
ED
but not muscle growth during 10 weeks of training. J Physiol 2014; 592:5391-5408. [49] Gomez-Cabrera M, Domenech E, Romagnoli M, Arduini A, Borras C, Pallardo F, et al.
PT
Oral administration of vitamin C decreases muscle mitochondrial biogenesis and hampers
CE
training-induced adaptations in endurance performance. Am J Clin Nutr 2008; 87:142-149.
AC
[50] Strobel NA, Peake JM, Matsumoto A, Marsh SA, Coombes JS, Wadley GD, et al. Antioxidant supplementation reduces skeletal muscle mitochondrial biogenesis. Med Sci Sports Exerc 2011; 43:1017-1024.
24
ACCEPTED MANUSCRIPT
Figure legends Fig. 1. Experimental design Fig. 2. Muscle weight after cast removal
CR IP T
Soleus (A) and gastrocnemius (B) muscle weight per body weight after cast removal. Data are presented as mean ± standard errors, n = 9. Within-group comparison was conducted using
AN US
paired t-test. ** p < 0.01. Fig. 3. Comparison of muscle weight in hypertrophic period
Soleus (A) and gastrocnemius (C) muscle weight per body weight in control and casted legs.
M
White bar shows the soleus or gastrocnemius muscle weight per body weight in the control leg
ED
and black bar shows the that of the casted leg. Comparisons within-group and between-group were conducted using two-way analysis of variance and Tukey test. Muscle mass was corrected
PT
by body weight. Relative weight of the casted leg compared to control leg in the soleus (B) and
CE
gastrocnemius (D) muscles. Between-group comparison was conducted using one-way analysis
AC
of variance and Dunnett’s test. Data are presented as mean ± standard errors, n = 7. * p < 0.05, ** p < 0.01.
Fig. 4. Comparison of protein metabolic signaling of the casted leg in hypertrophic period Phospho-mTOR (A), phospho-p70S6K (B), phospho-Akt (C), and phospho-FoxO1 (D) levels
25
ACCEPTED MANUSCRIPT
are expressed as relative value to the normal. Data are presented as mean ± standard errors, n = 6-7. Between-group comparison was conducted using one-way analysis of variance and
CR IP T
Dunnett’s test. * p < 0.05.
AN US
Fig. 5. Comparison of carbonylated protein concentrations in the soleus muscle of the casted leg in hypertrophic period
Data are presented as mean ± standard errors, n = 6-7. Between-group comparison was
AC
CE
PT
ED
M
conducted using one-way analysis of variance and Dunnett’s test. * p < 0.05.
26
Atrophy
Hypertrophy
Leg fixation with a cast for 3 weeks
Control or antioxidant diet for 2 weeks
AN US
Acclimatization for 1 week
CR IP T
ACCEPTED MANUSCRIPT
Removal of the cast Measurement 1
Measurement 2
Control group
Astaxanthin group
CE
PT
ED
M
β-carotene group
AC
Figure 1
27
Resveratrol group Mix group
A
B Gastrocnemius weight (mg/g B.W.)
**
0.2
0.1
0 Casted leg
AC
CE
Figure 2
PT
ED
M
Control leg
**
6 5 4
AN US
Soleus weight (mg/g B.W.)
0.3
CR IP T
ACCEPTED MANUSCRIPT
28
3
2 1 0
Control leg
Casted leg
B
A
30
*
**
Relative soleus weight (%)
*
0.3
0.2
0.1
0
20
*
10 0
AN US
Soleus weight (mg/g B.W.)
0.4
CR IP T
ACCEPTED MANUSCRIPT
-10 -20
**
*
p = 0.10
**
D
*
30
5
M
4 3
ED
2 1
0
Relative gastrocnemius weight (%)
6
PT
C
Gastrocnemius weight (mg/g B.W.)
-30
20 10 0
-10 -20
AC
CE
-30
Figure 3
29
Cont r ol
As t axant hi n
?- car ot ene
Res ver at r ol
Mi x
A
C
B *
*
100
0
Phospho-Akt (%)
200
150
300
200
100
AN US
Phospho-p70S6K (%)
Phospho-mTOR (%)
300
100
0
50
0
D
M
Phospho-mTOR
150 Phospho-FoxO1 (%)
CR IP T
ACCEPTED MANUSCRIPT
Phospho-FoxO1 Total FoxO1 GAPDH
AC
CE
0
Total p70S6K
Total Akt
PT
50
Phospho-p70S6K
Phospho-Akt
ED
100
Total mTOR
Figure 4
30
CR IP T
* 5.0
AN US
4.0 3.0
2.0 1.0 0.0
CE
PT
ED
M
Carbonylated protein (nmol/mg)
ACCEPTED MANUSCRIPT
AC
Figure 5
31